Article may be outdated

This article is 7 days old. Some details may have changed since publication.

Mirage News·3 min read·medium

Research Identifies Antidepressants That Help Patients Stay Well

Research Identifies Antidepressants That Help Patients Stay Well
✦AI Summary

A large-scale study published in The Lancet Psychiatry has identified three antidepressants—escitalopram, agomelatine, and duloxetine—as the most effective for long-term management of depression. The research analyzed data from over 30,000 participants to help clinicians make better treatment choices.

Why it matters

This study offers evidence-based guidance for long-term depression treatment, potentially improving patient outcomes and reducing relapse rates.

✦Dive DeeperCreate a free account to unlock

Antidepressants not only alleviate depression symptoms in the short term, but also help sustain these benefits over the longer term. A new, major comparative study has found that three medications are the most effective in this regard. 'This helps doctors choose a medication that not only helps patients to get well, but also keeps them well.'

Worldwide, nearly six percent of people experience depression. Many of them continue taking antidepressants after achieving symptomatic improvement, amongst others to prevent a relapse of depression. An international team of researchers investigated whether and which antidepressants in particular can not only get the patients well but also keep them well (sustained response). This is the first large-scale study to compare different antidepressants over both short- and long-term use. Results have now been published in The Lancet Psychiatry.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in